4.6 Article

Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson's disease and other synucleinopathies: SMARTSPEECH

期刊

BMJ OPEN
卷 12, 期 6, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2021-059871

关键词

Parkinson-s disease; Speech pathology; Audiology

资金

  1. Czech Ministry of Health [NU20--08--00445]

向作者/读者索取更多资源

Early identification of Parkinson's disease is crucial for the development of neuroprotective therapies, but accurate biomarkers for prodromal PD are lacking. The vocal assessment of patients with isolated rapid eye movement sleep behaviour disorder (iRBD) and PD shows potential as a diagnostic and progressive biomarker. This study collects speech patterns from iRBD, early PD and control participants using a smartphone application and expects to find significant increase in PD-related speech disorders. Ethics approval has been obtained, and the study findings will be published and presented at scientific conferences.
Introduction Early identification of Parkinson's disease (PD) in its prodromal stage has fundamental implications for the future development of neuroprotective therapies. However, no sufficiently accurate biomarkers of prodromal PD are currently available to facilitate early identification. The vocal assessment of patients with isolated rapid eye movement sleep behaviour disorder (iRBD) and PD appears to have intriguing potential as a diagnostic and progressive biomarker of PD and related synucleinopathies. Methods and analysis Speech patterns in the spontaneous speech of iRBD, early PD and control participants' voice calls will be collected from data acquired via a developed smartphone application over a period of 2 years. A significant increase in several aspects of PD-related speech disorders is expected, and is anticipated to reflect the underlying neurodegeneration processes. Ethics and dissemination The study has been approved by the Ethics Committee of the General University Hospital in Prague, Czech Republic and all the participants will provide written, informed consent prior to their inclusion in the research. The application satisfies the General Data Protection Regulation law requirements of the European Union. The study findings will be published in peer-reviewed journals and presented at international scientific conferences.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据